Displaying drugs 14426 - 14450 of 15379 in total
JNJ-17216498
JNJ-17216498 is a histamine receptor H3 antagonist developed by Johnson and Johnson for the treatment of narcolepsy.
Investigational
Matched Description: … JNJ-17216498 is a histamine receptor H3 antagonist developed by Johnson and Johnson for the treatment …
7-Hydroxystaurosporine
Experimental
Investigational
Zk-806450
Experimental
K-252a
Experimental
Quinaldic Acid
Experimental
D-galactohydroximo-1,5-lactam
Experimental
4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate
Experimental
CRA_10433
Experimental
2-Pyridinethiol
Experimental
SU9516
Experimental
6-bromoindirubin-3'-oxime
Experimental
Bisindolylmaleimide I
Experimental
CRA_9076
Experimental
N-Pyridoxyl-2-Methylalanine-5-Phosphate
Experimental
Coproporphyrinogen III
Experimental
(3s)-2,3,4,5-Tetrahydropyridin-3-Amine
Experimental
CRA_9678
Experimental
Displaying drugs 14426 - 14450 of 15379 in total